{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:26:02Z","timestamp":1775276762374,"version":"3.50.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04195-1","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:58:45Z","timestamp":1758877125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between the TyG index and MAFLD and its subtypes: a population-based cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1688-6748","authenticated-orcid":false,"given":"Cui\u2019e","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3163-3367","authenticated-orcid":false,"given":"Chaochen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4796-9858","authenticated-orcid":false,"given":"Jia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8783-6083","authenticated-orcid":false,"given":"Long","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1309-4216","authenticated-orcid":false,"given":"Man","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8775-0492","authenticated-orcid":false,"given":"Pei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0713-8347","authenticated-orcid":false,"given":"Meng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"1","key":"4195_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol."},{"issue":"7","key":"4195_CR2","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J. International Consensus Panel, MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology. 2020;158(7):1999-2014.e1.","journal-title":"Gastroenterology."},{"issue":"6","key":"4195_CR3","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jhep.2021.07.035","volume":"75","author":"D Kim","year":"2021","unstructured":"Kim D, Konyn P, Sandhu KK, Dennis BB, Cheung AC, Ahmed A. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States. J Hepatol. 2021;75(6):1284\u201391.","journal-title":"J Hepatol."},{"issue":"1","key":"4195_CR4","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1038\/s41598-022-05168-0","volume":"12","author":"AM Farrell","year":"2022","unstructured":"Farrell AM, Magliano DJ, Shaw JE, et al. A problem of proportions: estimates of metabolic associated fatty liver disease and liver fibrosis in Australian adults in the nationwide 2012 AusDiab Study. Sci Rep. 2022;12(1):1956.","journal-title":"Sci Rep."},{"issue":"Suppl 2","key":"4195_CR5","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s12072-024-10660-y","volume":"18","author":"J Zhao","year":"2024","unstructured":"Zhao J, Liu L, Cao YY, et al. MAFLD as part of systemic metabolic dysregulation. Hepatol Int. 2024;18(Suppl 2):834\u201347.","journal-title":"Hepatol Int."},{"key":"4195_CR6","doi-asserted-by":"publisher","first-page":"204201882211455","DOI":"10.1177\/20420188221145549","volume":"14","author":"RM Pipitone","year":"2023","unstructured":"Pipitone RM, Ciccioli C, Infantino G, et al. MAFLD: a multisystem disease. Ther Adv Endocrinol Metab. 2023;14:20420188221145548.","journal-title":"Ther Adv Endocrinol Metab."},{"issue":"1","key":"4195_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12933-022-01697-0","volume":"21","author":"XD Zhou","year":"2022","unstructured":"Zhou XD, Cai J, Targher G, et al. Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention. Cardiovasc Diabetol. 2022;21(1):270.","journal-title":"Cardiovasc Diabetol."},{"issue":"4","key":"4195_CR8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s12072-023-10543-8","volume":"17","author":"XD Zhou","year":"2023","unstructured":"Zhou XD, Targher G, Byrne CD, et al. An international multidisciplinary consensus statement on MAFLD and the risk of CVD. Hepatol Int. 2023;17(4):773\u201391.","journal-title":"Hepatol Int."},{"key":"4195_CR9","doi-asserted-by":"publisher","first-page":"1056562","DOI":"10.3389\/fendo.2022.1056562","volume":"13","author":"CH Lee","year":"2022","unstructured":"Lee CH, Lui DT, Li RH, et al. Sequential algorithm to stratify liver fibrosis risk in overweight\/obese metabolic dysfunction-associated fatty liver disease. Front Endocrinol (Lausanne). 2022;13:1056562.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"4","key":"4195_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304.","journal-title":"Metab Syndr Relat Disord."},{"issue":"12","key":"4195_CR11","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1016\/j.numecd.2022.07.024","volume":"32","author":"SA Nabipoorashrafi","year":"2022","unstructured":"Nabipoorashrafi SA, Seyedi SA, Rabizadeh S, et al. The accuracy of triglyceride-glucose (TyG) index for the screening of metabolic syndrome in adults: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2022;32(12):2677\u201388.","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"4195_CR12","doi-asserted-by":"publisher","first-page":"644035","DOI":"10.3389\/fcvm.2021.644035","volume":"8","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yang W, Jiang X. Association Between Triglyceride-Glucose Index and Hypertension: A Meta-Analysis. Front Cardiovasc Med. 2021;8:644035.","journal-title":"Front Cardiovasc Med."},{"issue":"1","key":"4195_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12933-023-02087-w","volume":"22","author":"F Xin","year":"2023","unstructured":"Xin F, He S, Zhou Y, Jia X, Zhao Y, Zhao H. The triglyceride glucose index trajectory is associated with hypertension: a retrospective longitudinal cohort study. Cardiovasc Diabetol. 2023;22(1):347.","journal-title":"Cardiovasc Diabetol."},{"key":"4195_CR14","doi-asserted-by":"publisher","first-page":"8757996","DOI":"10.1155\/2021\/8757996","volume":"2021","author":"Y Pan","year":"2021","unstructured":"Pan Y, Zhong S, Zhou K, et al. Association between Diabetes Complications and the Triglyceride-Glucose Index in Hospitalized Patients with Type 2 Diabetes. J Diabetes Res. 2021;2021:8757996.","journal-title":"J Diabetes Res."},{"issue":"4","key":"4195_CR15","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.clnu.2021.02.037","volume":"40","author":"X Xuan","year":"2021","unstructured":"Xuan X, Hamaguchi M, Cao Q, et al. U-shaped association between the triglyceride-glucose index and the risk of incident diabetes in people with normal glycemic level: A population-base longitudinal cohort study. Clin Nutr. 2021;40(4):1555\u201361.","journal-title":"Clin Nutr."},{"key":"4195_CR16","doi-asserted-by":"publisher","first-page":"774567","DOI":"10.3389\/fendo.2021.774567","volume":"12","author":"Z Qin","year":"2021","unstructured":"Qin Z, Zhao J, Geng J, Chang K, Liao R, Su B. Higher Triglyceride-Glucose Index Is Associated With Increased Likelihood of Kidney Stones. Front Endocrinol (Lausanne). 2021;12:774567.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"1","key":"4195_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12933-023-02055-4","volume":"22","author":"C Cui","year":"2023","unstructured":"Cui C, Liu L, Zhang T, et al. Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study. Cardiovasc Diabetol. 2023;22(1):325.","journal-title":"Cardiovasc Diabetol."},{"issue":"6","key":"4195_CR18","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.numecd.2023.03.026","volume":"33","author":"X Ren","year":"2023","unstructured":"Ren X, Jiang M, Han L, Zheng X. Association between triglyceride-glucose index and chronic kidney disease: A cohort study and meta-analysis. Nutr Metab Cardiovasc Dis. 2023;33(6):1121\u20138.","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"4195_CR19","doi-asserted-by":"publisher","first-page":"1400448","DOI":"10.3389\/fendo.2024.1400448","volume":"15","author":"S Wei","year":"2024","unstructured":"Wei S, Wu T, You Y, et al. Correlation between the triglyceride-glucose index and chronic kidney disease among adults with metabolic-associated fatty liver disease: fourteen-year follow-up. Front Endocrinol (Lausanne). 2024;15:1400448.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"1","key":"4195_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-019-0982-2","volume":"19","author":"J Alizargar","year":"2020","unstructured":"Alizargar J, Bai CH, Hsieh NC, Wu SV. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. Cardiovasc Diabetol. 2020;19(1):8.","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"4195_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12933-022-01541-5","volume":"21","author":"H Li","year":"2022","unstructured":"Li H, Zuo Y, Qian F, et al. Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):105.","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"4195_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12933-022-01658-7","volume":"21","author":"X Li","year":"2022","unstructured":"Li X, Chan J, Guan B, et al. Triglyceride-glucose index and the risk of heart failure: Evidence from two large cohorts and a mendelian randomization analysis. Cardiovasc Diabetol. 2022;21(1):229.","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"4195_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"4195_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-022-01606-5","volume":"21","author":"X Wang","year":"2022","unstructured":"Wang X, Xu W, Song Q, et al. Association between the triglyceride-glucose index and severity of coronary artery disease. Cardiovasc Diabetol. 2022;21(1):168.","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"4195_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12933-022-01664-9","volume":"21","author":"F Yan","year":"2022","unstructured":"Yan F, Yan S, Wang J, et al. Association between triglyceride glucose index and risk of cerebrovascular disease: systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):226.","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"4195_CR26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12933-023-01924-2","volume":"22","author":"XL Cai","year":"2023","unstructured":"Cai XL, Xiang YF, Chen XF, et al. Prognostic value of triglyceride glucose index in population at high cardiovascular disease risk. Cardiovasc Diabetol. 2023;22(1):198.","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"4195_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12933-023-02076-z","volume":"22","author":"H Zhou","year":"2023","unstructured":"Zhou H, Ding X, Lan Y, Chen S, Wu S, Wu D. Multi-trajectories of triglyceride-glucose index and lifestyle with Cardiovascular Disease: a cohort study. Cardiovasc Diabetol. 2023;22(1):341.","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"4195_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"4195_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12933-024-02269-0","volume":"23","author":"C Liu","year":"2024","unstructured":"Liu C, Liang D, Xiao K, Xie L. Association between the triglyceride-glucose index and all-cause and CVD mortality in the young population with diabetes. Cardiovasc Diabetol. 2024;23(1):171.","journal-title":"Cardiovasc Diabetol."},{"key":"4195_CR30","doi-asserted-by":"publisher","first-page":"1281839","DOI":"10.3389\/fendo.2023.1281839","volume":"14","author":"W Dong","year":"2023","unstructured":"Dong W, Gong Y, Zhao J, Wang Y, Li B, Yang Y. A combined analysis of TyG index, SII index, and SIRI index: positive association with CHD risk and coronary atherosclerosis severity in patients with NAFLD. Front Endocrinol (Lausanne). 2023;14:1281839.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"1","key":"4195_CR31","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12933-023-01919-z","volume":"22","author":"J Li","year":"2023","unstructured":"Li J, Dong Z, Wu H, et al. The triglyceride-glucose index is associated with atherosclerosis in patients with symptomatic coronary artery disease, regardless of diabetes mellitus and hyperlipidaemia. Cardiovasc Diabetol. 2023;22(1):224.","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"4195_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12933-023-01847-y","volume":"22","author":"H Yu","year":"2023","unstructured":"Yu H, Tao L, Li YG, et al. Association between triglyceride-glucose index trajectories and carotid atherosclerosis progression. Cardiovasc Diabetol. 2023;22(1):130.","journal-title":"Cardiovasc Diabetol."},{"issue":"5","key":"4195_CR33","first-page":"715","volume":"15","author":"LE Simental-Mend\u00eda","year":"2016","unstructured":"Simental-Mend\u00eda LE, Simental-Mend\u00eda E, Rodr\u00edguez-Hern\u00e1ndez H, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of triglycerides and glucose as biomarker for screening simple steatosis and NASH in asymptomatic women. Ann Hepatol. 2016;15(5):715\u201320.","journal-title":"Ann Hepatol"},{"issue":"4","key":"4195_CR34","doi-asserted-by":"publisher","first-page":"101345","DOI":"10.1016\/j.diabet.2022.101345","volume":"48","author":"B Rivi\u00e8re","year":"2022","unstructured":"Rivi\u00e8re B, Jaussent A, Macioce V, et al. The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients. Diabetes Metab. 2022;48(4):101345.","journal-title":"Diabetes Metab."},{"issue":"1","key":"4195_CR35","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12944-020-01393-6","volume":"19","author":"W Guo","year":"2020","unstructured":"Guo W, Lu J, Qin P, et al. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults. Lipids Health Dis. 2020;19(1):218.","journal-title":"Lipids Health Dis."},{"key":"4195_CR36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.clnesp.2021.04.025","volume":"44","author":"H Tutunchi","year":"2021","unstructured":"Tutunchi H, Naeini F, Mobasseri M, Ostadrahimi A. Triglyceride glucose (TyG) index and the progression of liver fibrosis: A cross-sectional study. Clin Nutr ESPEN. 2021;44:483\u20137.","journal-title":"Clin Nutr ESPEN."},{"key":"4195_CR37","doi-asserted-by":"publisher","first-page":"951689","DOI":"10.3389\/fendo.2022.951689","volume":"13","author":"Y Xue","year":"2022","unstructured":"Xue Y, Xu J, Li M, Gao Y. Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters. Front Endocrinol (Lausanne). 2022;13:951689.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"4195_CR38","doi-asserted-by":"publisher","first-page":"1124019","DOI":"10.3389\/fendo.2023.1124019","volume":"14","author":"V Furdela","year":"2023","unstructured":"Furdela V, Pavlyshyn H, Shulhai AM, Kozak K, Furdela M. Triglyceride glucose index, pediatric NAFLD fibrosis index, and triglyceride-to-high-density lipoprotein cholesterol ratio are the most predictive markers of the metabolically unhealthy phenotype in overweight\/obese adolescent boys. Front Endocrinol (Lausanne). 2023;14:1124019.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"2","key":"4195_CR39","doi-asserted-by":"publisher","first-page":"475","DOI":"10.47162\/RJME.62.2.13","volume":"62","author":"AM Amzolini","year":"2021","unstructured":"Amzolini AM, For\u0163ofoiu MC, Bar\u0103u Abu-Alhija A, et al. Triglyceride and glucose index: a useful tool for non-alcoholic liver disease assessed by liver biopsy in patients with metabolic syndrome. Rom J Morphol Embryol. 2021;62(2):475\u201380.","journal-title":"Rom J Morphol Embryol."},{"issue":"11","key":"4195_CR40","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.3390\/jcm11113043","volume":"11","author":"AM Amzolini","year":"2022","unstructured":"Amzolini AM, For\u021bofoiu MC, Alhija AB, et al. Triglyceride and Glucose Index as a Screening Tool for Nonalcoholic Liver Disease in Patients with Metabolic Syndrome. J Clin Med. 2022;11(11):3043.","journal-title":"J Clin Med."},{"issue":"9","key":"4195_CR41","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.3390\/jcm11092666","volume":"11","author":"A Beran","year":"2022","unstructured":"Beran A, Ayesh H, Mhanna M, et al. Triglyceride-Glucose Index for Early Prediction of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of 121,975 Individuals. J Clin Med. 2022;11(9):2666.","journal-title":"J Clin Med."},{"issue":"1","key":"4195_CR42","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12933-024-02392-y","volume":"23","author":"SS Nayak","year":"2024","unstructured":"Nayak SS, Kuriyakose D, Polisetty LD, et al. Diagnostic and prognostic value of triglyceride glucose index: a comprehensive evaluation of meta-analysis. Cardiovasc Diabetol. 2024;23(1):310.","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"4195_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12944-022-01661-7","volume":"21","author":"Z Liu","year":"2022","unstructured":"Liu Z, He H, Dai Y, et al. Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study. Lipids Health Dis. 2022;21(1):55.","journal-title":"Lipids Health Dis."},{"issue":"1","key":"4195_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40200-021-00941-w","volume":"21","author":"E Taheri","year":"2022","unstructured":"Taheri E, Pourhoseingholi MA, Moslem A, et al. The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults. J Diabetes Metab Disord. 2022;21(1):97\u2013107.","journal-title":"J Diabetes Metab Disord."},{"issue":"9","key":"4195_CR45","doi-asserted-by":"publisher","first-page":"e075413","DOI":"10.1136\/bmjopen-2023-075413","volume":"13","author":"R Yu","year":"2023","unstructured":"Yu R, Xie W, Peng H, et al. Diagnostic value of triglyceride-glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study. BMJ Open. 2023;13(9):e075413.","journal-title":"BMJ Open."},{"key":"4195_CR46","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.2147\/DMSO.S469859","volume":"17","author":"Z Cheng","year":"2024","unstructured":"Cheng Z, Hu C, Zhang Y, et al. The Different Predictive Effects of Multiple Body Fat Indexes on Metabolic Dysfunction-Associated Fatty Liver Disease. Diabetes Metab Syndr Obes. 2024;17:3875\u201390.","journal-title":"Diabetes Metab Syndr Obes."},{"key":"4195_CR47","first-page":"1","volume":"56","author":"G Zipf","year":"2013","unstructured":"Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999\u20132010. Vital Health Stat 1. 2013;56:1\u201337.","journal-title":"Vital Health Stat 1."},{"issue":"7","key":"4195_CR48","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamadermatol.2022.1609","volume":"158","author":"Z Ruan","year":"2022","unstructured":"Ruan Z, Lu T, Chen Y, et al. Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults. JAMA Dermatol. 2022;158(7):745\u201353.","journal-title":"JAMA Dermatol."},{"issue":"12","key":"4195_CR49","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1111\/liv.14675","volume":"40","author":"S Yamamura","year":"2020","unstructured":"Yamamura S, Eslam M, Kawaguchi T, et al. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int. 2020;40(12):3018\u201330.","journal-title":"Liver Int."},{"issue":"4","key":"4195_CR50","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/hep.26156","volume":"57","author":"D Kim","year":"2013","unstructured":"Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology. 2013;57(4):1357\u201365.","journal-title":"Hepatology."},{"issue":"15","key":"4195_CR51","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.3390\/nu14153052","volume":"14","author":"H Liu","year":"2022","unstructured":"Liu H, Wang L, Chen C, Dong Z, Yu S. Association between Dietary Niacin Intake and Migraine among American Adults: National Health and Nutrition Examination Survey. Nutrients. 2022;14(15):3052.","journal-title":"Nutrients."},{"key":"4195_CR52","doi-asserted-by":"publisher","first-page":"1466807","DOI":"10.3389\/fnut.2024.1466807","volume":"11","author":"M Zheng","year":"2024","unstructured":"Zheng M, Li C, Fu J, Bai L, Dong J. Association between composite dietary antioxidant index and fatty liver index among US adults. Front Nutr. 2024;11:1466807.","journal-title":"Front Nutr."},{"issue":"4S","key":"4195_CR53","first-page":"S1","volume":"100","author":"Kidney Disease","year":"2021","unstructured":"Disease Kidney. Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group, KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100(4S):S1\u2013276.","journal-title":"Kidney Int."},{"issue":"9","key":"4195_CR54","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1097\/JS9.0000000000001795","volume":"110","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Shen J, Chen P, et al. Association of triglyceride glucose index with stroke: from two large cohort studies and Mendelian randomization analysis. Int J Surg. 2024;110(9):5409\u201316.","journal-title":"Int J Surg."},{"issue":"1","key":"4195_CR55","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12933-022-01563-z","volume":"21","author":"Y Liao","year":"2022","unstructured":"Liao Y, Zhang R, Shi S, et al. Triglyceride-glucose index linked to all-cause mortality in critically ill patients: a cohort of 3026 patients. Cardiovasc Diabetol. 2022;21(1):128.","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"4195_CR56","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12933-023-01967-5","volume":"22","author":"H Zheng","year":"2023","unstructured":"Zheng H, Chen G, Wu K, et al. Relationship between cumulative exposure to triglyceride-glucose index and heart failure: a prospective cohort study. Cardiovasc Diabetol. 2023;22(1):239.","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"4195_CR57","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12933-022-01615-4","volume":"21","author":"J Wang","year":"2022","unstructured":"Wang J, Huang X, Fu C, Sheng Q, Liu P. Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome. Cardiovasc Diabetol. 2022;21(1):187.","journal-title":"Cardiovasc Diabetol."},{"issue":"14","key":"4195_CR58","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1002\/sim.7273","volume":"36","author":"R Puhr","year":"2017","unstructured":"Puhr R, Heinze G, Nold M, Lusa L, Geroldinger A. Firth\u2019s logistic regression with rare events: accurate effect estimates and predictions. Stat Med. 2017;36(14):2302\u201317.","journal-title":"Stat Med."},{"issue":"16","key":"4195_CR59","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/sim.1047","volume":"21","author":"G Heinze","year":"2002","unstructured":"Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med. 2002;21(16):2409\u201319.","journal-title":"Stat Med."},{"key":"4195_CR60","doi-asserted-by":"crossref","unstructured":"60. da Silva A, Quintino F, Almeida F, Aguiar D. Bias Reduction of Modified Maximum Likelihood Estimates for a Three-Parameter Weibull Distribution. Entropy (Basel). 2025; 27(5):485.","DOI":"10.3390\/e27050485"},{"issue":"2","key":"4195_CR61","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/j.jhep.2023.08.019","volume":"80","author":"N Luo","year":"2024","unstructured":"Luo N, Zhang X, Huang J, Chen H, Tang H. Prevalence of steatotic liver disease and associated fibrosis in the United States: Results from NHANES 2017-March 2020. J Hepatol. 2024;80(2):e70\u20131.","journal-title":"J Hepatol."},{"issue":"23","key":"4195_CR62","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.3390\/nu14234969","volume":"14","author":"J Wang","year":"2022","unstructured":"Wang J, Yan S, Cui Y, Chen F, Piao M, Cui W. The Diagnostic and Prognostic Value of the Triglyceride-Glucose Index in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Systematic Review and Meta-Analysis. Nutrients. 2022;14(23):4969.","journal-title":"Nutrients."},{"key":"4195_CR63","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.2147\/DMSO.S407657","volume":"16","author":"D Zhang","year":"2023","unstructured":"Zhang D, Zhang L, Chen S, Chen R, Zhang X, Bai F. Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease Among Hospital Staff. Diabetes Metab Syndr Obes. 2023;16:1221\u201334.","journal-title":"Diabetes Metab Syndr Obes."},{"key":"4195_CR64","doi-asserted-by":"publisher","first-page":"1083032","DOI":"10.3389\/fendo.2023.1083032","volume":"14","author":"H Peng","year":"2023","unstructured":"Peng H, Pan L, Ran S, et al. Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults. Front Endocrinol (Lausanne). 2023;14:1083032.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"5","key":"4195_CR65","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1089\/met.2023.0276","volume":"22","author":"AL Han","year":"2024","unstructured":"Han AL, Lee HK, Shin SR. Diagnostic Performance of Insulin Resistance Indices for Identifying Metabolic Dysfunction-Associated Fatty Liver Disease. Metab Syndr Relat Disord. 2024;22(5):402\u20139.","journal-title":"Metab Syndr Relat Disord."},{"key":"4195_CR66","doi-asserted-by":"publisher","first-page":"e943375","DOI":"10.12659\/MSM.943375","volume":"30","author":"K Trochimczyk","year":"2024","unstructured":"Trochimczyk K, Flisiak-Jackiewicz M, Bobrus-Chociej A, et al. Biochemical and Anthropometric Indices of Insulin Resistance in Obese and Overweight Children with Metabolic Dysfunction-Associated Fatty Liver Disease. Med Sci Monit. 2024;30:e943375.","journal-title":"Med Sci Monit."},{"key":"4195_CR67","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.2147\/DMSO.S383907","volume":"15","author":"R Zhang","year":"2022","unstructured":"Zhang R, Guan Q, Zhang M, et al. Association Between Triglyceride-Glucose Index and Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Cohort Study. Diabetes Metab Syndr Obes. 2022;15:3167\u201379.","journal-title":"Diabetes Metab Syndr Obes."},{"key":"4195_CR68","doi-asserted-by":"crossref","unstructured":"Abildgaard J, Aleliunaite A, Horvath C, et al. Sex Hormone-Binding Globulin Controls Sex-Specific Lipolytic Activity in Human Abdominal Subcutaneous Adipocytes. Mol Metab. 2025;98:102189.","DOI":"10.1016\/j.molmet.2025.102189"},{"key":"4195_CR69","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejim.2023.01.029","volume":"110","author":"ZQ Xie","year":"2023","unstructured":"Xie ZQ, Li HX, Wang BK, et al. Trends in prevalence and all-cause mortality of metabolic dysfunction-associated fatty liver disease among adults in the past three decades: Results from the NHANES study. Eur J Intern Med. 2023;110:62\u201370.","journal-title":"Eur J Intern Med."},{"issue":"1","key":"4195_CR70","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology."},{"key":"4195_CR71","doi-asserted-by":"crossref","unstructured":"71. Wu S, Pan J, Song M, Zhao YC, Chen W, Huang H, Zhu Y, Chen F. Performance of Magnetic Resonance Imaging and Ultrasound for Identifying the Different Degrees of Hepatic Steatosis: A Systematic Review and Meta-analysis. Acad Radiol. 2025:S1076-6332(25)00204-1 [pii].","DOI":"10.1016\/j.acra.2025.03.008"},{"issue":"2","key":"4195_CR72","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1148\/radiol.2017162931","volume":"286","author":"JH Runge","year":"2018","unstructured":"Runge JH, Smits LP, Verheij J, et al. MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis. Radiology. 2018;286(2):547\u201356.","journal-title":"Radiology."},{"key":"4195_CR73","doi-asserted-by":"crossref","unstructured":"73. Jia S, Zhao Y, Liu J, Guo X, Chen M, Zhou S, Zhou J. Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic Accuracy. Front Pediatr. 2021; 9:784221.","DOI":"10.3389\/fped.2021.784221"},{"key":"4195_CR74","doi-asserted-by":"publisher","first-page":"204062232110331","DOI":"10.1177\/20406223211033119","volume":"12","author":"CX Shao","year":"2021","unstructured":"Shao CX, Ye J, Dong Z, Li F, Lin Y, Liao B, Feng S, Zhong B. Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease. Ther Adv Chronic Dis. 2021;12:20406223211033120.","journal-title":"Ther Adv Chronic Dis."},{"key":"4195_CR75","unstructured":"75. Eslam M, Fan JG, Yu ML, et al. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease. Hepatol Int. 2025;1 9(2):261\u2013301."},{"issue":"5","key":"4195_CR76","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","volume":"66","author":"T Karlas","year":"2017","unstructured":"Karlas T, Petroff D, Sasso M, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66(5):1022\u201330.","journal-title":"J Hepatol."},{"key":"4195_CR77","doi-asserted-by":"publisher","first-page":"5121574","DOI":"10.1155\/2019\/5121574","volume":"2019","author":"A Kitae","year":"2019","unstructured":"Kitae A, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study. Can J Gastroenterol Hepatol. 2019;2019:5121574.","journal-title":"Can J Gastroenterol Hepatol."},{"issue":"2","key":"4195_CR78","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3803\/EnM.2019.34.2.179","volume":"34","author":"SB Lee","year":"2019","unstructured":"Lee SB, Kim MK, Kang S, et al. Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults. Endocrinol Metab (Seoul). 2019;34(2):179\u201386.","journal-title":"Endocrinol Metab (Seoul)."},{"issue":"11","key":"4195_CR79","doi-asserted-by":"publisher","first-page":"e039804","DOI":"10.1136\/bmjopen-2020-039804","volume":"10","author":"C Huanan","year":"2020","unstructured":"Huanan C, Sangsang L, Amoah AN, et al. Relationship between triglyceride glucose index and the incidence of non-alcoholic fatty liver disease in the elderly: a retrospective cohort study in China. BMJ Open. 2020;10(11):e039804.","journal-title":"BMJ Open."},{"issue":"6","key":"4195_CR80","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/s00431-021-03951-1","volume":"180","author":"LE Simental-Mend\u00eda","year":"2021","unstructured":"Simental-Mend\u00eda LE, Ortega-Pacheco CJ, Garc\u00eda-Guerrero E, Sicsik-Arag\u00f3n MA, Guerrero-Romero F, Mart\u00ednez-Aguilar G. The triglycerides and glucose index is strongly associated with hepatic steatosis in children with overweight or obesity. Eur J Pediatr. 2021;180(6):1755\u201360.","journal-title":"Eur J Pediatr."},{"issue":"3","key":"4195_CR81","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/ijerph18030857","volume":"18","author":"IT Lin","year":"2021","unstructured":"Lin IT, Lee MY, Wang CW, Wu DW, Chen SC. Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population. Int J Environ Res Public Health. 2021;18(3):857.","journal-title":"Int J Environ Res Public Health."},{"key":"4195_CR82","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.2147\/DMSO.S316864","volume":"14","author":"J Liu","year":"2021","unstructured":"Liu J, Guan L, Zhao M, et al. Association Between the Triglyceride-Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study. Diabetes Metab Syndr Obes. 2021;14:2829\u201339.","journal-title":"Diabetes Metab Syndr Obes."},{"key":"4195_CR83","doi-asserted-by":"publisher","first-page":"977625","DOI":"10.3389\/fendo.2022.977625","volume":"13","author":"H Li","year":"2022","unstructured":"Li H, Zhang Y, Luo H, Lin R. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults. Front Endocrinol (Lausanne). 2022;13:977625.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"1","key":"4195_CR84","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12933-024-02343-7","volume":"23","author":"Q Chen","year":"2024","unstructured":"Chen Q, Hu P, Hou X, et al. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):232.","journal-title":"Cardiovasc Diabetol."},{"key":"4195_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clnu.2025.04.006","volume":"49","author":"M Zhao","year":"2025","unstructured":"Zhao M, Liang C, Huang J, et al. Association between triglyceride-glucose related indices and severe infection requiring hospital admission or resulting in mortality among individuals with metabolic dysfunction-associated steatotic liver disease. Clin Nutr. 2025;49:1\u201310.","journal-title":"Clin Nutr."},{"issue":"1","key":"4195_CR86","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12933-025-02716-6","volume":"24","author":"Z Song","year":"2025","unstructured":"Song Z, Miao X, Liu S, et al. Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study. Cardiovasc Diabetol. 2025;24(1):154.","journal-title":"Cardiovasc Diabetol."},{"issue":"7","key":"4195_CR87","doi-asserted-by":"publisher","first-page":"102400","DOI":"10.1016\/j.clinre.2024.102400","volume":"48","author":"BA Priego-Parra","year":"2024","unstructured":"Priego-Parra BA, Reyes-Diaz SA, Ordaz-Alvarez HR, et al. Diagnostic performance of sixteen biomarkers for MASLD: A study in a Mexican cohort. Clin Res Hepatol Gastroenterol. 2024;48(7):102400.","journal-title":"Clin Res Hepatol Gastroenterol."},{"issue":"1","key":"4195_CR88","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-024-02572-w","volume":"24","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Wang Y, Chen C, Huang Y, Zhao C. Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank. Cardiovasc Diabetol. 2025;24(1):12.","journal-title":"Cardiovasc Diabetol."},{"issue":"4","key":"4195_CR89","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1053\/j.gastro.2023.06.013","volume":"165","author":"JJ Wattacheril","year":"2023","unstructured":"89, Wattacheril JJ, Abdelmalek MF, Lim JK, Sanyal AJ. AGA clinical practice update on the role of noninvasive biomarkers in the evaluation and management of nonalcoholic fatty liver disease: expert review. Gastroenterology. 2023;165(4):1080\u20138.","journal-title":"Gastroenterology"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04195-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04195-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04195-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:04:51Z","timestamp":1758881091000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04195-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4195"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04195-1","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study utilized de-identified, publicly available data from the National Health and Nutrition Examination Survey (NHANES). The original NHANES study protocol was reviewed and approved by the National Center for Health Statistics (NCHS) Research Ethics Review Board, and all participants provided written informed consent. Detailed documentation is available at: . As this secondary analysis exclusively used anonymized data in accordance with the Declaration of Helsinki, no additional institutional review board approval was required for the current study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"652"}}